UniSC Clinical Trials Moreton Bay
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Moller, Christopher
NCT05734040: Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Completed
2
478
RoW
OVX836 480µg, Fluarix Tetra, Afluria Quad, Placebo
Osivax, Novotech (Australia) Pty Limited, Mater Misericordiae Limited
Influenza
08/23
01/24
NCT06556147: A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Active, not recruiting
1
144
RoW
VXB-241 60 mcg (Low Dose), VXB-241 120 mcg (Medium Dose), VXB-241 240 mcg (Medium-high Dose), VXB-241 480 mcg (High Dose), VXB-241, Placebo, Arexvy 120 mcg
Vicebio Australia Proprietary Limited
Healthy Volunteers
08/25
05/27

Download Options